biotech · Plaque Psoriasis · Rheumatoid Arthritis · CANF
Can Fite Biopharma
Can-Fite BioPharma
Can Fite Biopharma clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 10 Bareket Street, פ"ת, IL, RAMAT GAN, L3, USA
- Employees
- 9
- Programs
- 20
- Drugs
- 4
- Patents
- 23
Can Fite Biopharma projects
7 ClinicalTrials.gov programs sponsored by Can Fite Biopharma.
Can Fite Biopharma has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CF101
Can-Fite BioPharma
Keratoconjunctivitis Sicca
2 trials -
CF101
Can-Fite BioPharma
Plaque Psoriasis
1 trial -
CF101 1 mg
Can-Fite BioPharma
Rheumatoid Arthritis
1 trial -
CF101 2mg
Can-Fite BioPharma
Plaque Psoriasis
1 trial -
Matching Placebo for Piclidenoson, Piclidenoson
Can-Fite BioPharma
Plaque psoriasis
1 trial -
Namodenoson
Can-Fite BioPharma
Hepatocellular Carcinoma
1 trial -
piclidenoson
Can-Fite BioPharma
Plaque Psoriasis
1 trial
Frequently asked questions
How many clinical projects does Can Fite Biopharma have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.